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Defining the functional binding sites of 
interleukin 12 receptor β1 and interleukin 23 
receptor to Janus kinases
ABSTRACT The interleukin (IL)-12–type cytokines IL-12 and IL-23 are involved in T-helper (Th) 
1 and Th17 immunity, respectively. They share the IL-12 receptor β1 (IL-12Rβ1) as one com-
ponent of their receptor signaling complexes, with IL-12Rβ2 as second receptor for IL-12 and 
IL-23R for IL-23 signal transduction. Stimulation with IL-12 and IL-23 results in activation of 
receptor-associated Janus kinases (Jak) and phosphorylation of STAT proteins in target cells. 
The Janus kinase tyrosine kinase (Tyk) 2 associates with IL-12Rβ1, whereas Jak2 binds to IL-
23R and also to IL-12Rβ2. Receptor association of Jak2 is mediated by Box1 and Box2 motifs 
located within the intracellular domain of the receptor chains. Here we define the Box1 and 
Box2 motifs in IL-12Rβ1 and an unusual Jak2-binding site in IL-23R by the use of deletion and 
site-directed mutagenesis. Our data show that nonfunctional box motifs abolish IL-12– and 
IL-23–induced STAT3 phosphorylation and cytokine-dependent proliferation of Ba/F3 cells. 
Coimmunoprecipitation of Tyk2 by IL-12Rβ1 and Jak2 by IL-23R supported these findings. In 
addition, our data demonstrate that association of Jak2 with IL-23R is mandatory for IL-12 
and/or IL-23 signaling, whereas Tyk2 seems to be dispensable.
INTRODUCTION
The proinflammatory interleukin (IL)-12 family members IL-12 and 
IL-23 are heterodimeric cytokines composed of the shared p40 sub-
unit and p35 or p19 (Garbers et al., 2012; Floss et al., 2015). IL-12 
and IL-23 have structural similarities but different functions in the 
immune system. IL-12 drives the development of T-helper (Th) 
1 cells mainly through the activation of STAT4. Th1 cells that pro-
duce interferon-γ (IFN-γ) are crucial for antimicrobial and antitumor 
responses (Trinchieri et al., 2003). IL-23 is important for the develop-
ment of Th17 cells, which mediate antimicrobial and antifungal re-
sponses and are characterized by the production of the cytokines 
IL-17A, IL-17F, and IL-21 (Park et al., 2005; Ouyang et al., 2008; Korn 
et al., 2009). Th1 and Th17 cells are involved in the pathogenesis of 
autoimmune diseases and chronic inflammatory disorders (Cosmi 
et al., 2014).
The IL-12 receptor β1 (IL-12Rβ1) is the shared receptor chain of 
the IL-12 and IL-23 receptor signaling complexes, which consist of 
IL-12Rβ1/IL-12Rβ2 and IL-12Rβ1/IL-23R, respectively (Presky et al., 
1996; Parham et al., 2002). IL-23 signaling is initiated by activation 
of tyrosine kinase (Tyk) 2 and Janus kinase (Jak) 2, which phosphory-
late predominantly STAT3 and to a lesser extent STAT1, STAT4, and 
STAT5 (Parham et al., 2002). The downstream signaling molecule of 
IL-12Rβ2 is predominantly STAT4 (Bacon et al., 1995b; Jacobson 
et al., 1995; Thierfelder et al., 1996) and to a lesser extent STAT1, 
STAT3, and STAT5 (Collison and Vignali, 2008). Tyk2 associates with 
IL-12Rβ1 and Jak2 with IL-12Rβ2 (Bacon et al., 1995a; Zou et al., 
1997). Phosphotyrosine-binding sites for STAT molecules have been 
found only in the intracellular domains of IL-12Rβ2 and IL-23R and 
not in IL-12Rβ1. Consequently they have been described as the only 
signal-transducing components of the IL-12 and IL-23 receptor 
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ing (Fischer et al., 1997). Previous studies demonstrated a crucial 
role of Jak1 for STAT3 activation in response to IL-6 (Guschin et al., 
1995; Aparicio-Siegmund et al., 2014). Comparable results were ob-
tained in gp130-expressing, kinase-deficient cell lines cotransfected 
with both IL-23 receptors. HIL-6 dependent STAT3 phosphorylation 
was greatly reduced in the absence of Jak1, but loss of Jak2 or Tyk2 
had no effect (Figure 1A). Western blot data demonstrated IL-23–
dependent tyrosine phosphorylation of STAT3 in cotransfected pa-
rental cell lines (2C4, 2fTGH) and Jak1-deficient cells (U4C). No sig-
nal was detected in Jak2 deficient fibrosarcoma cells (γ2A). In 
contrast, Tyk2-deficient U1A and parental 2fTGH cells showed com-
parable activation of STAT3 upon stimulation with IL-23 (Figure 1A). 
To confirm Tyk2 deficiency in U1A cells, we precipitated the kinase 
with a specific antibody and detected it by Western blotting (Figure 
1B). In addition, we found the presence of Jak1 and Jak2 (Figure 
1C). Cotransfection of COS-7 cells with cDNAs coding for IL-12Rβ1 
and Tyk2, Jak1, or Jak2 indicated that in the absence of Tyk2, Jak1 
takes over the kinase function (Figure 1D). These data demonstrate 
that Jak2 is crucial for IL-23 signaling, whereas Tyk2 is dispensable.
The intracellular domain of IL-12Rβ1 spanning amino 
acid residues 592–656 is crucial for IL-23–induced 
cellular proliferation and STAT3 phosphorylation
Murine IL-12Rβ1 consists of 738 amino acids. Its transmembrane 
domain is made up by amino acid residues 566–591 and its intracel-
lular domain (ICD) by amino acid residues 592–738 (Chua et al., 
1995; UniProtKB: Q60837). To analyze sequence requirements for 
IL-23–induced signaling within the intracellular domain of the IL-
12Rβ1, we initially generated a set of eight different IL-12Rβ1 vari-
ants containing various deletions of the intracellular domain (Figure 
2A). The cDNAs coding for the full-length IL-12Rβ1 (WT) protein and 
its deletions were stably transduced into Ba/F3-gp130-IL-23R cells 
expressing murine IL-23R (Floss et al., 2013). Ba/F3 cells are ideal to 
study cytokine signaling because their proliferation depends on IL-3 
and activation of STAT5. After stable transfection with a cDNA cod-
ing for gp130, proliferation of Ba/F3-gp130 cells and activation of 
STAT3 depends on IL-6 and soluble IL-6R or HIL-6. The correct cel-
lular location of the various IL-12Rβ1 variants was shown by cell sur-
face staining followed by flow cytometry analysis (Figure 2B).
We then analyzed IL-23 signaling by measuring cell proliferation 
and STAT3 activation. Ba/F3-gp130-IL-23R-IL-12Rβ1 (WT) cells with 
WT receptors proliferated in the presence of HIL-23, whereas Ba/
F3-gp130 cells expressing only IL-23R or IL-12Rβ1 did not grow 
(Floss et al., 2013; Figure 3A). Next, we compared IL-23–induced 
proliferation of Ba/F3-gp130-IL-23R cells, stably transduced with 
cDNAs coding for each of the eight IL-12Rβ1 variants, with IL-
12Rβ1 WT cells. For this purpose, we stimulated cells with saturat-
ing concentrations of either HIL-6 or HIL-23. Given that the cell lines 
were all independent cell clones and differed slightly in their maxi-
mal proliferation speed/capacity, we calculated IL-23–induced pro-
liferation as percentage of HIL-6–induced proliferation, which was 
set to 100%. As shown in Figure 3A, we did not detect differences 
in the proliferation of Ba/F3-gp130-IL-23R-IL-12Rβ1 cells (WT) stim-
ulated with either HIL-6 or HIL-23. However, proliferation was abol-
ished in the Ba/F3-gp130-IL-23R-IL-12Rβ1Δ595, -Δ607, -Δ621, and 
-Δ628 cell lines upon IL-23 stimulation. In contrast, IL-23–induced 
cellular proliferation of Ba/F3-gp130-IL-23R-IL-12Rβ1Δ657 and 
-Δ699 cells was undistinguishable from that of Ba/F3-gp130-IL-23R-
IL-12Rβ1 (WT) cells, whereas IL-23–induced proliferation of Ba/F3-
gp130-IL-23R-IL-12Rβ1Δ634 and -Δ638 cells was about fourfold 
reduced compared with Ba/F3-gp130-IL-23R-IL-12Rβ1 (WT) cells 
(Figure 3A).
complexes (Collison and Vignali, 2008). Recently a noncanonical 
tyrosine-independent STAT3 activation site was identified within IL-
23R (Floss et al., 2013). The IL-12Rβ1 was not found to contribute to 
IL-12/IL-23–induced intracellular signaling and is therefore consid-
ered as a ligand-binding receptor (Wu et al., 2000). However, p40 
homodimers induce macrophage migration via the IL-12Rβ1 (Ha 
et al., 1999), suggesting a role of IL-12Rβ1 in signal transduction 
(Russell et al., 2003). IL-12 signaling is mediated through tyrosine 
residues within IL-12Rβ2 (Watford et al., 2003). In humans, tyrosine 
at position 800 is critical for STAT4 activation (Naeger et al., 1999), 
whereas the tyrosines at positions 757, 804, and 811 are important 
for STAT4 and tyrosines at positions 737, 804, and 811 for STAT3 
activation in mice (Nishikomori et al., 2002). SOCS3 is recruited to 
human IL-12Rβ2 the interaction with the phosphorylated tyrosine at 
position 800 and thereby inhibits IL-12–induced activation of STAT4 
(Yamamoto et al., 2003). STAT-initiated signaling via the IL-12Rβ1 is 
unlikely, since the human IL-12Rβ1 contains no tyrosine residue and 
the murine IL-12Rβ1 contains only one (Y635), which is not embed-
ded in a classical STAT-binding motif (Chua et al., 1995). Therefore 
it needs to be investigated whether Y635 is phosphorylated during 
IL-12/IL-23 signal transduction.
The intracellular domain of the IL-12Rβ1 contains two predicted 
Box1 and Box2 motifs as docking sites for Tyk2, which are conserved 
in human and mouse IL-12Rβ1 proteins (Chua et al., 1995). Whereas 
IL-23R does not contain conserved Box1 and Box2 motifs, the bind-
ing site of Jak2 at the IL-23R has been predicted (Pidasheva et al., 
2011). Box1 motifs are highly conserved among many cytokine re-
ceptors (Ihle and Kerr, 1995; Murakami et al., 1991). These motifs 
are proline-rich, ∼6–10 amino acid residues long, and located in 
close proximity to the transmembrane domain. The consensus se-
quence of Box1 motifs is ΦΦP1X(I/V)P2XP3(E/K) (Φ denotes hydro-
phobic amino acid; Usacheva et al., 2002), where P1 and P2 are al-
ways present in cytokine receptors that associate with Jak2 
(Usacheva et al., 2002). The Box2 motif is not exactly defined but is 
characterized by the consensus sequence (V/L)E(V/L)L (ΦEΦΦ; 
Usacheva et al., 2002). Box1 is needed for the association of the 
Janus kinase to the receptor chain (Tanner et al., 1995), whereas 
Box2 somehow mediates the full activity of the associated Janus ki-
nase (Fukunaga et al., 1991; Colosi et al., 1993; Usacheva et al., 
2002). The Janus kinase–binding regions within the IL-12Rβ1 and 
the IL-23R were not characterized.
Here we define the Box1 and Box2 motifs in murine IL-12Rβ1 
and an unusual Jak2-binding site in IL-23R. Functional analysis re-
vealed that association of Jak2 to IL-23R is mandatory for IL-12 and 
IL-23 signaling, whereas the function of Tyk2 can be taken over by 
another kinase.
RESULTS
Jak kinase activation upon IL-23 stimulation
It has been shown that the same spectra of Jak/STAT molecules as in 
IL-12 signaling are activated by IL-23. IL-23R, like IL-12Rβ2, interacts 
with Jak2 to initiate signaling (Parham et al., 2002). To confirm the 
requirement for Jak2 and Tyk2 in IL-23 signal transduction, we co-
transfected human fibrosarcoma cells (2C4 and 2fTGH) and cells that 
are deficient in Jak1 (U4C), Jak2 (γ2A), or Tyk2 (U1A; Behrmann 
et al., 2004) with the cDNAs for murine IL-23R and IL-12Rβ1 (Figure 
1A). Expression analysis of both receptors performed by Western 
blotting revealed comparable levels. The cotransfected cells were 
incubated in the absence or presence of hyper–IL (HIL)-23. IL-23 sig-
naling was assessed by analysis of STAT3 activation using immuno-
blotting. HIL-6 stimulation was included as control. HIL-6 is a fusion 
protein of IL-6 and the soluble IL-6R, which mimics IL-6 trans-signal-
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Analysis of IL-23 signaling by activation of 
STAT3 was investigated in either stably trans-
duced Ba/F3 cells or transiently transfected 
U4C cells expressing IL-23R and the IL-12Rβ1 
(WT) or the variant IL-12Rβ1Δ628, -Δ634, 
-Δ638, -Δ657, or -Δ699. Consistent with the 
cellular proliferation results, IL-23–induced 
STAT3 phosphorylation was observed in 
cells expressing IL-23R and full-length 
IL-12Rβ1 (WT) or IL-12Rβ1Δ657 or -Δ699. 
Coexpression of IL-23R and IL-12Rβ1Δ628, 
however, did not result in STAT3 phosphory-
lation. Deletion of the murine IL-12Rβ1 at 
amino acid residue 633 or 637 resulted in 
reduction of STAT3 phosphorylation, which 
is in agreement with the slight proliferation 
of these cells. Although Ba/F3-gp130-
IL-23R-IL-12Rβ1Δ638 cells had a somewhat 
higher STAT3 phosphorylation in the ab-
sence of IL-23 (basal pSTAT3 level), IL-23 
stimulation only slightly increased STAT3 
phosphorylation (Figure 3B). Expression of 
IL-23R and IL-12Rβ1 in transiently trans-
fected U4C cells was confirmed by Western 
blotting (Figure 3C). Taken together, our 
data demonstrate that amino acid residues 
657–738 of IL-12Rβ1 were not critically re-
quired for cellular proliferation and STAT3 
activation. Moreover, amino acid residues 
N592 to P627, which flank the proposed 
Box1 motif of the IL-12Rβ1, rescue ∼20% of 
biological activity, whereas the amino acid 
residues N592 to Q656 were required for full 
activity. This indicates that the proposed 
Box1 and Box2 motifs are required for kinase 
binding and induction of IL-23 signaling.
Verification of the proposed Box1 
and Box2 motifs for Tyk2 binding 
and IL-23/IL-12–induced signaling
Sequence homology comparison of the in-
tracellular domains of IL-12Rβ1 from differ-
ent species revealed a highly conserved 
amino acid residue stretch from murine 
L598 to C606 (LCPPLPTPC), which shows 
similarity to the Box1 consensus sequence 
(φφPX(I/V)PXP(E/K) (Usacheva et al., 2002). 
A second motif, which is not exactly de-
fined, was found in the murine V641-E653 
sequence (VVEMPGDRGDGTE) and might 
serve as Box2 motif (φEφφ; Usacheva et al., 
2002; Figure 4A). To verify the proposed 
Box1 and Box2 motifs, we generated 
appropriate amino acid deletions of mu-
rine IL-12Rβ1 (ΔBox1: mIL-12Rβ1Δ595-606, 
ΔBox2: mIL-12Rβ1-Δ638-656). In addition, 
we mutated three proline residues within 
the Box1 to valine in the mIL-12Rβ1 variant 
mIL-12Rβ1P601V/P603V/P605V (Figure 4B). 
Expression of the murine IL-12Rβ1 variants 
and IL-23R on the cell surface of generated 
Ba/F3 cell lines was confirmed by flow cy-
tometry (Figure 4C).
FIGURE 1: Tyk2 is dispensable in IL-23 signal transduction. (A) Kinase-deficient fibrosarcoma cell 
lines γ2A (lacking Jak2), U4C (lacking Jak1), and U1A (lacking Tyk2) and the parental cell lines 
2C4 and 2fTGH were cotransfected with expression plasmids for IL-23 receptors. At 30 h after 
transfection, cells were washed with PBS and starved overnight in serum-free medium. Cells 
were then stimulated with 0.2% HIL-6 for 15 min or 0.2% HIL-23 for 30 min. Cellular lysates were 
prepared, and 50 μg of total protein (31 μg for HIL-6 stimulation) per lane was loaded on SDS 
gels, followed by immunoblotting using specific antibodies for phospho-STAT3, STAT3, mIL-23R, 
and mIL-12Rβ1. Three independent experiments were performed and one representative 
experiment is shown. (B) Confirmation of Tyk2 absence in U1A cells. Tyk2 was 
immunoprecipitated from cellular lysates, and Western blotting was performed to detect the 
kinase. The arrow highlights the precipitated Tyk2 in 2fTGH cells. One representative 
experiment out of three is shown. IP, immunoprecipitation; L, lysate. (C) Detection of Jak1 and 
Jak2 in Tyk2-deficient U1A cells after immunoprecipitation. Cellular lysates were prepared and 
subjected to immunoprecipitation, followed by Western blotting. One representative 
experiment is shown. (D) Jak1 associates with IL-12Rβ1 in the absence of Tyk2. COS-7 cells were 
transiently transfected with cDNAs coding for IL-12Rβ1 and either Tyk2, Jak1 or Jak2. Kinases 
were immunoprecipitated and Western blotting was performed to detect IL-12Rβ1 and the 
appropriate kinase. One representative experiment out of three is shown.
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IL-23–stimulated, cotransfected U4C cells 
containing IL-23R and the IL-12Rβ1 Box2 
deletion variant (Δ638-656; Figure 4, E and 
F). These results show that Box1 is manda-
tory for IL-23–induced signaling, whereas 
Box2 is not essential but needed to achieve 
full activity.
The kinases Tyk2 and Jak2 are involved 
in IL-12 signaling (Watford et al., 2003), and 
direct association of Jak2 with IL-12Rβ2 and 
Tyk2 with IL-12Rβ1 has been shown (Zou 
et al., 1997). We investigated the binding of 
Tyk2 to mIL-12Rβ1 variants by coimmuno-
precipitation approaches. As expected, 
IL-12Rβ1 was coimmunoprecipitated with 
Tyk2, whereas binding of IL-12Rβ1Δ595 
(deletion of Box1 and Box2) and IL-
12Rβ1Δ595-606 (deletion Box1) to Tyk2 was 
greatly diminished (Figure 4G). Unspecific 
bands of lower molecular weight were de-
tected in lysates and immunoprecipitates of 
each variant. However, bands with the ap-
propriate molecular weight for the IL-12Rβ1 
deletion variants were significantly reduced 
in the coimmunoprecipitates, indicating that 
the Box1 motif is essential for binding of the 
Janus kinase Tyk2 to IL-12Rβ1.
IL-12Rβ1 is required not only for IL-23–in-
duced signal transduction but also for IL-12 
signaling. To verify our results for IL-12 sig-
naling, we generated Ba/F3-gp130 cells sta-
bly transduced with murine IL-12Rβ1 (and 
variants thereof) and the murine IL-12Rβ2, 
making these cells responsive to IL-12. 
Correct location of the receptors on the 
cell surface of stably transduced Ba/F3 cells 
was confirmed by flow cytometry (Figure 
5A). As shown in Figure 5B, proliferation of 
Ba/F3-gp130-IL-12Rβ2-IL-12Rβ1 (WT) was 
dependent on HIL-12, whereas single trans-
duced cells with IL-12Rβ1 or IL-12Rβ2 and 
Ba/F3-gp130 cells did not proliferate in the 
presence of the cytokine. As expected, Ba/
F3-gp130-IL-12Rβ2 expressing the IL-12Rβ1 
variants -Δ628, -Δ634, -Δ595-656, and 
-P601V/P603V/P605V did not proliferate in the 
presence of HIL-12. As for IL-23–induced 
cellular proliferation, Ba/F3-gp130-IL-12Rβ2 
cells expressing mIL-12Rβ1 variants -Δ638-
656 and -Δ638 showed reduced IL-12–de-
pendent proliferation, whereas IL-12–in-
duced proliferation of Ba/F3-gp130-IL-12Rβ2-IL-12Rβ1Δ657 cells 
was only slightly reduced and more comparable to that of WT Ba/
F3-gp130-IL-12Rβ2-IL-12Rβ1 cells (Figure 5B).
IL-12 induces STAT4, STAT1, and STAT3 phosphorylation but ap-
parently not Erk1/2 activation (Zou et al., 1997; Watford et al., 2003). 
Due to very low levels of STAT4 protein in Ba/F3 cells (Zou et al., 
1997), our analysis was focused on activation of STAT1 and 3. West-
ern blot analysis of IL-12–induced STAT1/3 phosphorylation was per-
formed with stably transduced Ba/F3 cell lines. Only double trans-
duction of the cDNAs coding for IL-12Rβ1 and IL-12Rβ2 led to 
IL-12–induced STAT1/3 phosphorylation (Figure 5C). Cotransduction 
We analyzed IL-23–dependent proliferation of stably transduced 
Ba/F3-gp130-IL-23R-IL-12Rβ1Δ595-606, -Δ638-656, and -P601V/
P603V/P605V cells. Whereas deletion or mutation of the Box1 motif 
completely abolished IL-23–induced proliferation, deletion of Box2 
resulted in a markedly reduced but detectable cellular proliferation 
(Figure 4D). Analysis of IL-23–induced STAT3 phosphorylation in 
either stably transduced Ba/F3 or transiently transfected U4C cells 
supported the results of the cellular proliferation. STAT3 phosphory-
lation was undetectable in IL-12Rβ1 variants with a deleted or mu-
tated Box1 motif and slightly detectable in the IL-12Rβ1 variant with 
the deleted Box2 motif. No STAT3 phosphorylation was detected in 
FIGURE 2: Analysis of the intracellular domain of IL-12Rβ1 for signal transduction. (A) The 738–
amino acid mouse IL-12Rβ1 is a transmembrane protein containing Box1 and Box2 motifs within 
the ICD. Eight deletion variants were generated by PCR, and the first amino acid of the missing 
part of the IL-12Rβ1 cytoplasmic domain is noted (e.g., Δ594). The extracellular (ED) and the 
transmembrane domain (TM) of IL-12Rβ1 were unaffected. (B) Representative histograms of 
IL-12Rβ1 (top) and IL-23R (bottom) surface expression of stably transduced Ba/F3-gp130 cell 
lines. Gray-shaded areas indicate Ba/F3-gp130 cells (negative control), and dark solid lines are 
the respective Ba/F3 cell lines as indicated.
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(2003), clearly induced activation of Erk1/2 was detected for Ba/F3 
cells expressing IL-12Rβ2 and WT IL-12Rβ1 upon IL-12 stimulation. 
Slight phosphorylation of Erk1/2 was also shown for the IL-12Rβ2/
IL-12β1Δ657 variant (Figure 5C). As already shown for IL-23–induced 
STAT3 phosphorylation, the amino acid residues (634–656) near the 
Box2 motif (642–653) of IL-12Rβ1 are also important for the activa-
tion of the Erk1/2 pathway (Figure 5C).
of IL-12Rβ2 and IL-12Rβ1Δ595-606, -Δ628, and -Δ638 did not lead 
to IL-12–induced STAT1/3 phosphorylation. However, IL-12–stimu-
lated Ba/F3 cells expressing IL-12Rβ2 and IL-12Rβ1Δ657 induced 
STAT1/3 phosphorylation comparable to that of WT cells (Figure 5C), 
which is consistent with IL-12–dependent proliferation (Figure 5B). 
We also investigated these stable cell lines for their ability to phos-
phorylate Erk1/2. In contrast to the assumption of Watford et al. 
FIGURE 3: The cytoplasmic domain of mouse IL-12Rβ1 is important for STAT3 activation. (A) Proliferation of stably 
cotransduced Ba/F3-gp130 cells with cDNAs coding for murine IL-23R and murine IL-12Rβ1 (WT) or appropriate 
deletion variants. Equal numbers of cells were cultured for 3 d in the presence of 0.2% HIL-6–conditioned cell culture 
supernatant or 0.2% HIL-23 or without cytokine. Parental Ba/F3-gp130 cells were used as control. Proliferation was 
measured using the colorimetric CellTiter-Blue Cell Viability Assay. HIL-6–dependent proliferation was set to 100%. One 
representative experiment is shown. Error bars represent SD for technical replicates. (B) Stably transduced Ba/F3 cells 
were washed three times, starved, and stimulated with 0.2% HIL-23 for 30 min. Cellular lysates were prepared, and 
equal amounts of total protein (50 μg/lane) were loaded on SDS gels, followed by immunoblotting using specific 
antibodies for phospho-STAT3 and STAT3. Western blot data show one representative experiment out of three. (C) U4C 
cells were transiently transfected with cDNAs for murine IL-23R and IL-12Rβ1 variants. At 30 h after transfection, cells 
were washed with PBS and starved overnight in serum-free medium. Cells were then stimulated with HIL-23 for 30 min. 
Cellular lysates were prepared, and equal amounts of total protein (50 μg/lane) were loaded on SDS gels, followed by 
immunoblotting using specific antibodies for phospho-STAT3, STAT3, mIL-23R, and mIL-12Rβ1. Nontransfected U4C 
cells served as negative control (C). Western blot data show one representative experiment out of three.
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FIGURE 4: Association of Tyk2 with IL-12Rβ1 via the Box1 motif is mandatory for IL-23 signal transduction. (A) Aligned 
amino acid sequences of IL-12Rβ1. The transmembrane domain of the mouse IL-12Rβ1 is highlighted in bold. Box1 and 
Box2 motifs are as described in Chua et al. (1995). Deletion variants are depicted by triangles. (B) IL-12Rβ1 variants with 
mutated or deleted Box motifs were generated by PCR. The extracellular (ED) and the transmembrane domain (TM) of 
IL-12Rβ1 are unaffected. (C) Representative histograms of IL-12Rβ1 (top) and IL-23R (bottom) surface expression of 
stably transduced Ba/F3-gp130 cell lines. Gray-shaded areas indicate Ba/F3-gp130 cells (negative control), and dark 
solid lines are the respective Ba/F3 cell lines as indicated. (D) Proliferation of stably cotransduced Ba/F3-gp130 cells with 
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parable to that of wild-type cells, whereas Y416FΔ503 failed to in-
duce proliferation of the respective Ba/F3 cells (Figure 6E). Despite 
the interaction of Jak2 and IL-23RΔ480, Ba/F3 cells expressing IL-
12Rβ1 and the latter variant failed to proliferate in the presence of 
IL-23. Analysis of IL-23–dependent Jak2 phosphorylation by Western 
blotting clearly demonstrated activation of the kinase exclusively in 
Ba/F3-gp130-IL-12Rβ1 cells expressing IL-23R WT or -Δ503 (Figure 
6F) but not in -Δ415, -Y416FΔ415, -Δ455, -Δ480, and -Y416FΔ503 
variants. We previously showed that STAT3 phosphorylation is not 
mandatory for the proliferation of Ba/F3-gp130-IL-12Rβ1-
IL-23RΔ503 cells, which is maintained by activation of Erk1/2 and/or 
PI3K/Akt (Floss et al., 2013). IL-23–dependent STAT3 phosphoryla-
tion was exclusively detected in Ba/F3-gp130-IL-12Rβ1-IL-23R WT 
cells, whereas activation of Erk1/2 occurs also in cells expressing the 
IL-23RΔ503 variant (Figure 6F).
The foregoing results indicated that association of Jak2 with the 
IL-23R receptor does not necessarily implicate kinase activation 
upon stimulation with IL-23. In fact, our data suggest that the ICD 
spanning amino acid residues N396 to E479 of the IL-23R is impor-
tant for activation of Jak2. To identify the region within the ICD re-
quired for kinase association/activation, we generated a second set 
of IL-23R variants (Figure 7A) and tested their interaction with Jak2. 
Surprisingly, interaction of Jak2 and IL-23R was detected for all IL-
23R variants, including those that carry a deletion in the proposed 
Jak2-binding site (Δ403-417; Pidasheva et al., 2011), and two IL-23R 
mutants that contain amino acid changes located next to (single 
nucleotide polymorphism [SNP] R400Q) or within (Y416F) the postu-
lated Jak2-binding site (Figure 7B). Ba/F3-gp130-IL-12Rβ1-IL-23R 
cells were analyzed with regard to the cell surface expression of the 
receptors (Figure 7C) and their proliferation in the presence of HIL-
23. Deletion of the postulated Jak2-binding site was further done in 
the IL-23R variant with Y → F substitutions of four tyrosines (FFFF; 
Y416F/Y504F/Y542F/Y626F). Cell viability assays revealed that dele-
tion of the putative Jak2- binding site from Δ403-417 and all other 
deletions abolished IL-23–dependent cellular proliferation. In con-
trast, IL-23–induced cellular proliferation of Ba/F3-gp130-IL-12Rβ1-
IL-23R-R400Q cells was comparable to that for Ba/F3-gp130-
IL-12Rβ1-IL-23R cells (Figure 7D). Analysis of Jak2, STAT3, and 
Erk1/2 phosphorylation confirmed the results of the cell viability as-
say (Figure 7E). No STAT3 and Erk1/2 activation was observed for all 
deletion variants, demonstrating that the amino acid residues 403–
479 are indispensable for signal transduction. For the R400Q variant 
and the IL-23R-Y416F/Y504F/Y542F/Y626F variant, an apparently 
Taken together, our data indicate that the identified Box1 motif 
in the murine IL-12Rβ1 from 595 to 606 (LCPPLPTPC) is absolutely 
mandatory for IL-12– and IL-23–induced signal transduction. The 
identified Box2 motif is involved in STAT3 phosphorylation, but its 
deletion did not completely abolish signal transduction and cellular 
proliferation.
Characterization of the binding site of Jak2 within the 
intracellular domain of the IL-23R
So far, consensus sequence homology comparisons within the intra-
cellular domain of IL-23R did not lead to the identification of Box1 
and Box2 motifs (Figure 6A). However, sequence alignments of IL-
23R intracellular chains from different species suggested a conserved 
region from I403 to E417 in murine IL-23R as a potential Jak2-bind-
ing site (Pidasheva et al., 2011). Polymorphisms in the IL-23R chain 
may influence IL-23 responses, and a nonsynonymous nucleotide 
substitution in the human IL23R gene, which results in the R381Q 
variant, showed a protective role against autoimmune diseases (Di 
Cesare et al., 2009). The R381Q polymorphism is conserved across 
different species (mouse R400Q) and is located between the trans-
membrane domain and the postulated Jak2 binding site. In vitro–po-
larized Th17 cells from IL-23R R381Q donors failed to induce IL-23–
mediated IL-17A production and STAT3 phosphorylation, possibly 
due to impaired association of Jak2 with the cytoplasmic domain of 
the receptor (Pidasheva et al., 2011). However, this hypothesis has 
not been functionally proven. A series of IL-23R deletion and muta-
tion variants (-Δ415, -Y416FΔ446, -Δ503, -Y416FΔ503) was character-
ized according to their ability to activate STAT3 (Floss et al., 2013).
In this study, we tested two additional variants (-Δ455 and -Δ480), 
whose cell surface expression has been verified by flow cytometry 
(Figure 6, B and C). To investigate the interaction of Jak2 and IL-23R 
and variants thereof, we verified the interaction of Jak2 with full-
length IL-23R (WT) and the deletion variants -Δ480, -Δ503, and 
-Y416F/Δ503 by coimmunoprecipitation experiments (Figure 6D). 
Although cotransfection of COS-7 cells with the WT receptor and 
Jak2 was not as efficient as for the other variants, we detected weak 
signals for the precipitated receptor and Jak2 in Western blots. In 
contrast, we detected no interaction of Jak2 and IL-23R for the 
IL-23RΔ415, -Y416FΔ446, and -Δ455 variants (Figure 6D). Consis-
tent with these results, the corresponding Ba/F3-gp130-IL-12Rβ1-
IL-23RΔ415, -IL-23R-Y416FΔ446, and –IL-23RΔ455 cells did not 
proliferate in the presence of HIL-23. However, Ba/F3-gp130-
IL-12Rβ1-IL-23RΔ503 showed IL-23–dependent proliferation com-
cDNAs coding for murine IL-23R and murine IL-12Rβ1 Box1 or Box2 deletion variants or mutant IL-12Rβ1. Equal 
numbers of cells were cultured for 3 d in the presence of 0.2% HIL-6 or 0.2% HIL-23 or without cytokine. Ba/F3-gp130 
cells expressing murine IL-23R and IL-12Rβ1 were used as control. Proliferation was measured using the colorimetric 
CellTiter-Blue Cell Viability Assay, and HIL-6–dependent proliferation was set to 100%. Error bars represent SD for 
technical replicates. (E) Stably transduced Ba/F3 cells were washed three times, starved, and stimulated with 0.2% 
HIL-23 for 30 min. Cellular lysates were prepared, and equal amounts of total protein (50 μg/lane) were loaded on SDS 
gels, followed by immunoblotting using specific antibodies for phospho-STAT3 and STAT3. Western blot data show one 
representative experiment out of three. (F) U4C cells were transiently transfected with cDNAs for murine IL-23R and 
IL-12Rβ1 deletion and mutant variants. Cotransfected U4C cells expressing wild-type receptors were used as control. At 
30 h after transfection, cells were washed with PBS and starved overnight in serum-free medium. Cells were then 
stimulated with HIL-23 for 30 min. Cellular lysates were prepared, and 50 μg of total protein per lane was loaded on 
SDS gels, followed by immunoblotting using specific antibodies for phospho-STAT3, STAT3, mIL-23R, and mIL-12Rβ1. 
Nontransfected U4C cells served as negative control (C). Western blot data show one representative experiment. 
(G) The Box1 motif of IL-12Rβ1 is important for the association of Tyk2. COS-7 cells were cotransfected with cDNAs 
coding for murine Tyk2 and full-length IL-12Rβ1, a deletion variant lacking Box1 motif, or an IL-12Rβ1 variant without 
the cytoplasmic domain. Tyk2 was immunoprecipitated, and Western blot analysis was performed to detect the 
appropriate IL-12Rβ1 variant and Tyk2. Three independent experiments were performed, and one representative 
experiment is shown. IP, Tyk2 coimmunoprecipitation; L, lysate.
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FIGURE 5: IL-12Rβ1 plays a central role in IL-12 signal transduction. (A) Selected IL-12Rβ1 variants were retrovirally 
transduced in Ba/F3-gp130-IL-12Rβ2 cells. Representative histograms of IL-12Rβ1 (top) and IL-12Rβ2 (bottom) surface 
expression of resulting transduced Ba/F3-gp130 cell lines. Gray-shaded areas indicate Ba/F3-gp130 cells (negative 
control), and dark solid lines are the respective Ba/F3 cell lines as indicated. (B) Proliferation of stably transduced Ba/
F3-gp130-IL-12Rβ2 cells with cDNAs coding for murine IL-12Rβ1 (WT) or appropriate variants. Equal numbers of cells 
were cultured for 3 d in the presence of 0.2% HIL-6–conditioned cell culture supernatant or 0.4% HIL-12 or without 
cytokine. Parental Ba/F3-gp130, Ba/F3-gp130-mIL-12Rβ1, and Ba/F3-gp130-mIL-12Rβ2 cells were used as 
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Biological effects of IL-12 and IL-23 are mediated by nonrecep-
tor protein tyrosine kinases, which phosphorylate tyrosine residues 
on the intracellular domains of the receptor chains. The signal-trans-
ducing component is either IL-12Rβ2 or IL-23R. Specific interactions 
were detected between Tyk2 and IL-12Rβ1 and between Jak2 and 
IL-12Rβ2, using IL-12 receptor chimeras containing the extracellular 
domain of epidermal growth factor receptor, as well as the trans-
membrane and cytoplasmic domains of either IL-12Rβ1 or IL-12Rβ2 
(Zou et al., 1997). Accordingly, IL-23R associates with Jak2 (Parham 
et al., 2002). We demonstrated that association and activation of 
Tyk2 are essential for IL-12– and IL-23–induced signal transduction. 
Our data showed that IL-12Rβ1 is not only a bystander receptor for 
binding of the cytokine. The intracellular part of IL-12Rβ1 is impor-
tant for signal transduction of IL-12 and IL-23, as visualized by recep-
tor deletion variants. Analysis of kinase-deficient fibrosarcoma cells 
showed that Jak2 is indispensable for IL-23 signal transduction. Ini-
tial studies showed that generation of Jak2-knockout mice led to 
embryonic lethality due to defects in erythropoiesis (Neubauer 
et al., 1998; Parganas et al., 1998). In contrast, Tyk2-deficient mice 
are viable but show impaired cytokine responses (Karaghiosoff 
et al., 2000; Shimoda et al., 2000). Neither IL-12 nor IL-23 induced 
STAT4 activation in T-cells from a Tyk2-deficient patient (Minegishi 
et al., 2006). However, STAT3 phosphorylation upon IL-23 stimula-
tion was not analyzed in this study. Because STAT4 activation is the 
main signaling event after IL-12 stimulation, STAT3 phosphorylation 
seems to be dominated by IL-23 (Watford et al., 2004). We exam-
ined Tyk2-deficient fibrosarcoma cells expressing both IL-23 recep-
tors in regard to activation of STAT3 upon stimulation with IL-23. 
Tyk2 deficiency did not abolish IL-23 signaling, indicating that STAT3 
was activated by another kinase, which may substitute for Tyk2. Co-
immunoprecipitation of IL-12Rβ1 from COS-7 cells transiently trans-
fected with cDNAs coding for IL-12Rβ1 and either Tyk2, Jak1, or 
Jak2 suggests the binding of Jak1 in the absence of Tyk2. Substitu-
tion of Janus kinases within the Jak-STAT pathway was shown by 
analysis of chimeric human IFN-γR2 receptors (Kotenko et al., 1996). 
Consequently a model was hypothesized in which signal- transduc-
ing receptor chains can be divided into two classes: 1) the actual 
signal transducers (ST) with STAT (or SH2 domain–containing pro-
teins) recruitment sites (SRS) and Jak association sites (JAS), and 
2) helper receptors (HR) containing only JAS and no SRS (Kotenko 
et al., 1996). In this model, IL-12Rβ1 represents the so-called helper 
receptor, which does not contain functional tyrosine residues but 
has additional protein tyrosine kinase activity upon IL-12 or IL-23 
binding. Kotenko et al. (1996) hypothesized that the intracellular do-
mains of HR can be associated with any Jak isoform and thus do not 
provide any specificity for signal transduction. Only the extracellular 
domains of helper receptors are specific for particular ligand–recep-
tor complexes. This hypothesis can be transferred to the IL-12 and 
IL-23 signaling complexes (Figure 8). In this case, the signal trans-
ducers for IL-12 or IL-23 signaling are IL-12Rβ2 and IL-23R, respec-
tively, and tyrosines involved in IL-12 and IL-23 signaling have been 
identified (Watford et al., 2004; Floss et al., 2013). This assumption 
is supported by the fact that removal of Jak association sites within 
weaker STAT3 phosphorylation was detected than with Ba/F3-
gp130-IL-12Rβ1-IL-23R cells (Figure 7F). We previously showed that 
this receptor variant possess altered kinetics of STAT3 activation 
(Floss et al., 2013). Consistent with STAT3 activation, phosphoryla-
tion of Jak2 was reduced in these cells. The IL-23R-Y416F and 
-R400Q variants activated Erk upon stimulation with IL-23, in con-
trast to cells with Y416F-mutated IL-23R lacking 120 amino acids of 
the intracellular part (-Y416F Δ503) or harboring mutations of signal-
transducing tyrosines (-Y416F/Y504F/Y542F/Y626F; Figure 7F). We 
previously showed that the predicted SHP2-binding site Y416EDI 
and an additional motif within the C-terminal part of the IL-23R are 
needed for phosphorylation of Erk1/2 (Floss et al., 2013).
Taken together, our results indicate that the amino acid sequence 
spanning E455 to E479 is critical for Jak2 binding. To identify the 
region required for Jak2 binding, we analyzed additional deletion 
variants, -Δ455-479, -Δ446-479, and -Δ403-479. We included a vari-
ant lacking the postulated Jak2-binding site (-Δ403-433) and one 
IL-23R protein with the lack of 12 amino acids after the postulated 
site (-Δ419-433). However, all of these receptor deletion variants, 
including Δ403-479, coimmunoprecipitate with Jak2 (Figure 7B). IL-
23 receptors in which parts of the intracellular domain have been 
removed (Δ403-433, Δ419-433, Δ446-479, Δ455-479, and Δ403-
479) showed a strong reduction in cell viability (Figure 7D). These 
results indicate that despite Jak2 association with the IL-23R recep-
tor, activation of IL-23 signaling did not occur. Our data clearly show 
that association of Jak2 with the IL-23R is not mediated via classical 
Box1/Box2 motifs and that the amino acid sequence E455 to E479 
is important but not sufficient for Jak2 activation. Considering the 
lack of IL-23–dependent proliferation of Ba/F3-IL-12Rβ1 cells ex-
pressing IL-23R variants with deletions of the previously proposed 
Jak2- binding site (Δ403-417, Δ403-433, Δ419-433, Δ446-479, 
Δ455-479, Δ403-479; Figure 7D), it is likely that other receptor se-
quences contribute to the regulation of the kinase activity.
DISCUSSION
Two members of the Janus kinase family are involved in signaling of 
IL-12–type cytokines: Jak2 and Tyk2 for IL-12 and IL-23, and Jak2 
and Jak1 for IL-27 and IL-35 (Vignali and Kuchroo, 2012). Here we 
characterized the Tyk2- and Jak2-binding sites in IL-12Rβ1 and IL-
23R, respectively. Tyk2 binding to IL-12Rβ1 was mediated by ca-
nonical Box1 and Box2 motifs for IL-12– and IL-23–induced receptor 
complexes. In contrast, IL-23R does not contain Box1 and Box2 mo-
tifs. Furthermore, the recently proposed Jak2-binding site I403 to 
E417 in the close vicinity of the plasma membrane was not respon-
sible for Jak2 binding. Instead, Jak2 binds to the amino acid se-
quence E455 to E479 of IL-23R. Surprisingly, E455 is ∼60 amino acid 
residues away from the plasma membrane. Taken together, our data 
indicate that Jak2 association with IL-23R is mandatory for IL-23 sig-
naling. However, despite binding of Jak2 to the IL-23R kinase, acti-
vation occurs only in IL-23R variants with intact cellular domains 
spanning N396 to T503 (WT, Δ503). Phosphorylation of Jak2 in Ba/
F3-IL-12Rβ1 cells expressing these variants induced activation of 
STAT proteins and/or Erk, leading to cell proliferation.
control. Proliferation was measured using the colorimetric CellTiter-Blue Cell Viability Assay. HIL-6–dependent 
proliferation was set to 100%. Error bars represent SD for technical replicates. (C) Stably transduced Ba/F3 cells were 
washed three times, starved, and stimulated with 0.2% HIL-6 or 0.4% HIL-12 for 15 or 30 min. Cellular lysates were 
prepared, and 50 μg of total protein per lane was loaded on SDS gels, followed by immunoblotting using specific 
antibodies for phospho-STAT3, STAT3, phospho-STAT1, STAT1, phospho-Erk1/2, and Erk1/2. Ba/F3-gp130-mIL-12Rβ1 
and Ba/F3-gp130-mIL-12Rβ2 cells were used as control. Western blot data show one representative experiment.
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FIGURE 6: The membrane-proximal region of IL-23R is important for association with Jak2. (A) Aligned amino acid 
sequences of IL-23R. The transmembrane domain of the mouse IL-23R is underlined. The hypothetical Jak2 binding 
motif as postulated by Pidasheva et al. (2011) is highlighted and highly conserved among different species. Mouse SNP 
R400Q, Y416, E433, E455, and Y496 are shown in bold. (B) Schematic representation of mIL-23R deletion variants. Six 
deletion variants were generated, and the first amino acid of the missing part of the IL-23R cytoplasmic domain (CD) is 
indicated (e.g., Δ415). The extracellular (ED) and the transmembrane domain (TM) of IL-23R are unaffected. Tyrosines 
within the CD are highlighted in black (Y416, Y504, Y542, and Y626, involved in IL-23 signaling) and white (Y448, Y469, 
and Y496). Y416F is indicated as F. (C) Representative histograms of IL-23R (top) and IL-12Rβ1 (bottom) surface 
expression of transduced Ba/F3-gp130 cell lines. Gray-shaded areas indicate Ba/F3-gp130 cells (negative control), and 
dark solid lines are the respective Ba/F3 cell lines as indicated. (D) Amino acid sequence from 455 to 479 is important 
for the association of Jak2. COS-7 cells were cotransfected with cDNAs coding for murine Jak2 (V5 tagged) and 
full-length IL-23R or a set of deletion variants (Floss et al., 2013). Jak2 was immunoprecipitated, and Western blot 
analysis was performed to detect the appropriate IL-23R variant and Jak2. Three independent experiments were 
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Coexpression of IL-12Rβ1 and IL-23R or the R381Q variant in HeLa 
cells resulted in decreased STAT3 activation upon IL-23 stimulation 
(Sarin et al., 2011). These results coincide with our data for the cor-
responding murine SNP R400Q. Ba/F3-IL-12Rβ1 cells expressing 
IL-23R R400Q proliferate in the presence of IL-23 but have reduced 
STAT3 activation, which is similar to behavior of an IL-23R (FFFF) 
containing mutations of STAT3 tyrosine residues (Floss et al., 2013). 
However, cotransduction of T-cell blasts from a patient with a null 
mutation of IL-12Rβ1 with IL-12Rβ1 and IL-23R WT or R381Q 
showed a similar activation of STAT1, STAT3, and STAT4 upon IL-23 
stimulation. Proliferation of these cells also showed no significant 
differences (De Paus et al., 2008).
Of interest, the identified Jak2-binding site in the IL-23R from 
E455 to E479 shows no homology to Box1 and Box2 motifs and is 
located ∼60 amino acids from the plasma membrane. The question 
arises of why the functional Jak2 binding site in the IL-23R is so far 
from the membrane, whereas all known Box1 motifs are in close 
proximity to the transmembrane domain. One explanation might be 
that Jak2 is redirected to the membrane by a special tertiary struc-
ture of the intracellular domain of the receptor, thereby facilitating 
Jak2 activation after cytokine stimulation. Alternatively, Jak2 bind-
ing to IL-23R is an exception, and the far location of Jak2 still en-
ables receptor activation. Of interest, deletion of the proposed 
Jak2-binding site from I403 to E417 also disrupted receptor activa-
tion but not Jak2 binding. Folding of the intracellular domain and 
functional location of Jak2 in a near-membrane position might be 
part of the explanation of why the deletion of the IL-23R amino acids 
I403 to E417 is crucial for IL-23–induced signal transduction and cel-
lular proliferation.
MATERIALS AND METHODS
Cells and reagents
COS-7 (ACC-60) cells were purchased from the Leibniz Institute 
DSMZ-German Collection of Microorganisms and Cell Cultures 
(Braunschweig, Germany). Human fibrosarcoma cell lines 2C4, U4C, 
γ2A, 2fTGH, and U1A have been described (Behrmann et al., 2004). 
G418 (Genaxxon Biosciences, Ulm, Germany; 400 μg/ml) was added 
to the medium of 2C4, U4C, and γ2A cells, and 2fTGH and U1A cells 
were supplemented with 125 or 250 μg/ml hygromycin B (Carl Roth 
GmbH, Karlsruhe, Germany). Murine Ba/F3-gp130 cells transduced 
with human gp130 were provided by Immunex (Seattle, WA) (Gear-
ing et al., 1994). The packaging cell line Phoenix-Eco was described 
previously (Ketteler et al., 2002). Ba/F3-gp130 cell lines with murine 
IL-12Rβ1 and murine IL-23R (WT), deletion (Δ415, Y416FΔ446, Δ503, 
Y416FΔ503), and mutation variants (Y416F, FFFF) were described 
previously (Floss et al., 2013). All cell lines were grown in DMEM 
high-glucose culture medium (GIBCO, Thermo Fisher Scientific, 
Waltham, MA) supplemented with 10% fetal calf serum (GIBCO, 
Thermo Fisher Scientific), 60 mg/l penicillin, and 100 mg/l streptomy-
cin (Genaxxon Bioscience) at 37°C with 5% CO2 in a water-saturated 
atmosphere. Ba/F3-gp130 cells were maintained in the presence of 
HIL-6, a fusion protein of IL-6 and the soluble IL-6R, which mimics 
the helper receptor IL-12Rβ1 completely prevents IL-23 and IL-12 
signal transduction.
Association of Tyk2 and IL-12Rβ1 is mediated by a Box1 motif, 
which is located within the intracellular part of the receptor. We 
demonstrated that deletion or mutation of this motif clearly inhib-
ited cytokine signaling. Deletion of the second motif (Box2) reduced 
but did not abolish IL-23 and IL-12 signal transduction. Early studies 
of GM-CSFRβ and GH receptor revealed that Box2 motifs positively 
modulate signaling for these two receptors but are not absolutely 
required for signaling (Sakamaki et al., 1992; Colosi et al., 1993). 
Based on the hypothesized signal transducer/helper receptor 
model, IL-23R should also contain at least one association site for 
Jak2. However, classical Box1 and Box2 motifs (Usacheva et al., 
2002) within the intracellular domain of the receptor have not been 
identified by amino acid sequence comparison. Recently a putative 
Jak2-binding site was predicted without any functional analysis 
(Pidasheva et al., 2011). Ba/F3-IL-12Rβ1 cells expressing IL-23R, 
which lack this motif, did not activate STAT3 and did not proliferate 
upon stimulation with IL-23. However, Jak2 is still associated with 
the IL-23R deletion variant. Coprecipitation of Jak2 and IL-23R was 
obtained for all analyzed receptor variants except three deletion 
variants, -Δ415, -Y416FΔ446, and -Δ455. Activation of Jak2 was ex-
clusively found in cells expressing IL-12Rβ1 and either IL-23R WT or 
-Δ503. We demonstrated that Ba/F3-IL-12Rβ1 cells expressing ei-
ther the Δ415 or Y416FΔ446 mutant fail to activate STAT3 and cel-
lular proliferation upon IL-23 stimulation (Floss et al., 2013). Wallwe-
ber et al. (2014) identified an unexpected receptor-binding mode in 
the Tyk2-IFNAR1 interface and described a glutamate residue 
(E497) in IFNAR1 that is required for Tyk2 binding. Of note, a classi-
cal proline-rich Box1 motif does not occur in IFNAR1. However, this 
glutamate, which is ∼40 amino acids away from the transmembrane 
domain, is in close vicinity to a dileucine motif important for the Tyk2 
FERM-SH2 domain stability. They speculated that the dileucine in-
teraction site might represent a Box1-binding motif for Jak kinase(s). 
Our results indicate that the amino acid residues E455 to E479 of 
murine IL-23R are important for association with Jak2. However, the 
proximal IL-23R cytoplasmic tail is also essential for IL-23 signaling. 
The polymorphism R381Q, which occurs at a frequency of up to 
17%, depending on the population, confers protection against in-
flammatory bowel diseases, psoriasis, ankylosing spondylitis, and 
graft-versus-host disease (De Paus et al., 2008). Several studies con-
sidered that R381Q IL-23R might result in a loss of function. CD8+ 
T-cells from healthy R381Q IL-23R carriers showed decreased IL-23–
dependent IL-17 and IL-22 production compared with WT individu-
als. Furthermore, Sarin et al. (2011) found decreased IL-23–depen-
dent expansion and STAT3 activation of CD8+ T-cells from R381Q 
individuals compared with WT cells. In parallel, Di Meglio et al. 
(2013) showed that the IL23R R381Q gene variant had no major ef-
fect on Th17 cell differentiation, but IL-23–mediated Th17 cell effec-
tor function was impaired. Th17 cells from R381Q carriers had sig-
nificantly reduced IL-23–induced IL-17A production and STAT3 
phosphorylation compared with WT carriers (Di Meglio et al., 2011). 
performed, and one representative experiment is shown. IP, Jak2 coimmunoprecipitation; L, lysate. (E) Proliferation of 
stably transduced Ba/F3-gp130-IL-12Rβ1 cells with cDNAs coding for murine IL-23R (WT) or appropriate variants. Equal 
numbers of cells were cultured for 3 d in the presence of 0.2% HIL-6–conditioned cell culture supernatant or 0.2% 
HIL-23 or without cytokine. Proliferation was measured using the colorimetric CellTiter-Blue Cell Viability Assay. 
HIL-6–dependent proliferation was set to 100%. Error bars represent SD for technical replicates. (F) Jak2 association 
does not implement kinase activation. Stably transduced Ba/F3 cells were washed three times, starved, and stimulated 
with HIL-23. Cellular lysates were prepared, and 50 μg of total protein per lane were loaded on SDS gels, followed by 
immunoblotting using specific antibodies for phospho-Jak2, Jak2, phospho-STAT3, STAT3, phospho-Erk1/2, and Erk1/2. 
Western blot data show one representative experiment out of three.
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FIGURE 7: Mutations and deletions of IL-23R ICD cannot disrupt Jak2 association. (A) Schematic representation of 
mIL-23R variants with mutations and deletions within the cytoplasmic domain (CD). Two mutation (R400Q and Y416F) 
and six deletion variants were generated. The extracellular (ED) and transmembrane (TM) domains of IL-23R are 
unaffected. Tyrosines within the CD are highlighted in black (Y416, Y504, Y542, and Y626, involved in IL-23 signaling) 
and white (Y448, Y469, and Y496). Y416F and R400Q are indicated. (B) COS-7 cells were cotransfected with cDNAs 
coding for murine Jak2 (V5 tagged) and full-length IL-23R or a deletion/mutant variant. Jak2 was immunoprecipitated, 
and Western blot analysis was performed to detect the appropriate IL-23R variant and Jak2. Three independent 
experiments were performed, and one representative experiment is shown. IP, Jak2 coimmunoprecipitation; L, lysate. 
(C) Representative histograms of IL-23R (top) and IL-12Rβ1 (bottom) surface expression of transduced Ba/F3-gp130 cell 
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murine IL-12Rβ1 or variants were stimulated 
with HIL-12. HIL-12 is a fusion protein of mu-
rine p40 followed by a synthetic linker 
(RGGGGSGGGGSVE) and murine p35 with 
an N-terminal Flag and a C-terminal histidine 
(His) tag. A stable CHO-K1 clone was se-
lected, and 0.4% of conditioned cell culture 
medium from this clone was used for cell cul-
ture and proliferation assays in a final concen-
tration of 4 ng/ml, as determined by ELISA 
(unpublished data). Phospho-STAT3 (Tyr-705) 
(D3A7), STAT3 (124H6), phospho-STAT1 (Tyr-
701), STAT1, phos pho-p44/42 MAPK (Erk1/2) 
(Thr-202/Tyr-204;D13.14.4E), p44/42 MAPK 
(Erk1/2) antibody, phospho-Jak2 (Tyr-
1007/1008), and Jak2 (D2E12) monoclonal 
antibodies (mAbs) were obtained from Cell 
Signaling Technology (Frankfurt, Germany). 
V5 mAb was purchased from Invitrogen, 
Thermo Fisher Scientific. Tyk2 (C-20) and 
Jak1 (HR-785) polyclonal antibodies were ob-
tained from Santa Cruz Biotechnology (Dal-
las, TX). The Tyk2 rabbit polyclonal antibody 
was raised against an N-terminal peptide of 
murine Tyk2 (Prchal-Murphy et al., 2012). 
Peroxidase-conjugated secondary mAbs 
were obtained from Pierce (Thermo Fisher 
Scientific). Biotinylated mIL-23R (BAF1686) 
and mIL-12Rβ1 (BAF1998) mAbs, streptavi-
din–horseradish peroxidase (HRP), phycoery-
thrin (PE)-conjugated mIL-12Rβ1, and 
mIL-23R mAbs were from R&D Systems (Min-
neapolis, MN). Purified hamster mIL-12Rβ2 
and PE mouse Armenian and Syrian hamster 
immunoglobulin G (IgG) cocktail were pur-
chased from BD Biosciences (Heidelberg, 
Germany). Alexa Fluor 647–conjugated Fab 
goat anti-rat IgG was obtained from Dianova 
(Hamburg, Germany).
Cloning of IL-12Rβ1, IL-12Rβ2, and IL-23R variants
Generation of the eukaryotic expression vector p409 (Althoff et al., 
2001) and the retroviral plasmid pMOWS-hygro (Suthaus et al., 
2010) containing the cDNA encoding murine IL-12Rβ1 were de-
scribed elsewhere (Floss et al., 2013). cDNA coding for murine 
IL-12Rβ2 (gene ID 16162) was amplified from total RNA extracts 
derived from mouse T-cells and cloned into p409 expression vector 
and the pMOWS-puro retroviral plasmid (Ketteler et al., 2002). A 
C-terminal c-myc tag was added. IL-12Rβ1 variants with truncated 
intracellular domains were cloned using standard PCR. Mutations of 
proline to valine in the Box1 motif of IL-12Rβ1 were introduced by 
IL-6 trans-signaling (Fischer et al., 1997). Either recombinant protein 
(10 ng/ml) or 0.2% of conditioned cell culture medium from a stable 
CHO-K1 clone secreting HIL-6 (final concentration 20 ng/ml as deter-
mined by enzyme-linked immunosorbent assay [ELISA]) was used to 
supplement the growth medium. Ba/F3-gp130-IL-23R-IL-12Rβ1 cells 
expressing murine IL-23R and murine IL-12Rβ1 or variants thereof 
were stimulated with 0.2% of conditioned cell culture medium from a 
stable CHO-K1 clone secreting HIL-23 (a fusion of murine p40 and 
murine p19) in a final concentration of 10 ng/ml, as determined by 
ELISA (unpublished data; Floss et al., 2013). Accordingly, Ba/F3-
gp130-IL-12Rβ2-IL-12Rβ1 cells containing the murine IL-12Rβ2 and 
lines. Gray-shaded areas indicate Ba/F3-gp130 cells (negative control), and dark solid lines are the respective Ba/F3 cell 
lines as indicated. (D) Proliferation of stably transduced Ba/F3-gp130-mIL-12Rβ1 cells with cDNAs coding for murine 
IL-23R (WT) or appropriate variants. Equal numbers of cells were cultured for 3 d in the presence of 0.2% HIL-6–
conditioned cell culture supernatant or 0.2% HIL-23 or without cytokine. Proliferation was measured using the 
colorimetric CellTiter-Blue Cell Viability Assay. HIL-6–dependent proliferation was set to 100%. Error bars represent SD 
for technical replicates. (E, F) Stably transduced Ba/F3 cells were washed three times, starved, and stimulated with 
HIL-23. Cellular lysates were prepared, and 50 μg total protein per lane was loaded on SDS gels, followed by 
immunoblotting using specific antibodies for phospho-Jak2, Jak2, phospho-STAT3, STAT3, phospho-Erk1/2, and Erk1/2. 
Western blot data show one representative experiment out of three.
FIGURE 8: Overview of Jak-binding sites within the IL-23 receptor complex. Formation of the 
IL-23 receptor complex consisting of p19, p40, IL-23R, and IL-12Rβ1 results in the activation 
of signaling pathways (Floss et al., 2015), and interaction of Janus kinases with the 
intracellular domains of the receptors initiates signaling cascades. According to Kotenko et al. 
(1996), IL-23R represents the signal transducer (ST) with a Janus kinase association site (JAS) 
and STAT recruitment sites (SRS). IL-12Rβ1 is regarded as a helper receptor (HR), which 
contains Box1 and Box2 motifs for association of the protein tyrosine kinase (PTK) Tyk2 or 
Jak1 and no SRS. Tyrosines within the IL-23R cytoplasmic domain are highlighted in black 
(Y416, Y504, Y542, and Y626, involved in IL-23 signaling) and white (Y448, Y469, and Y496). 
Postulated JAS I403-E417 is indicated (Pidasheva et al., 2011). Experimentally validated JAS 
E455-E479 is highlighted. Amino acid sequences that might influence kinase activity are 
designated.
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NaCl, 2 mM EDTA, 1 mM NaF, 1 mM Na3VO4, 1% Nonidet P-40, 
and 1% Triton X-100 supplemented with complete protease in-
hibitor cocktail tablets (Roche Diagnostics, Mannheim, Germany). 
Ba/F3-gp130 cell lines were washed three times with sterile PBS 
and incubated in serum-free DMEM for at least 4 h. Cells were 
stimulated with HIL-23, HIL-12, or HIL-6 as indicated, harvested, 
frozen in liquid nitrogen, and lysed as described. For analysis of 
phospho-Jak2, cells were lysed in 10 mM Tris-HCl, pH 7.8, 150 mM 
NaCl, 0.5 mM EDTA, 0.5% NP-40, 1 mM sodium vanadate, 
and 10 mM MgCl2 supplemented with complete protease inhibi-
tor cocktail tablets. Protein concentration of cell lysates was de-
termined by bicinchoninic acid protein assay (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. Analysis of 
Jak2, STAT1/3, and Erk1/2 activation was done by immunoblot-
ting using 50 μg of proteins from total cell lysates and using phos-
pho-Jak2, phospho-STAT1, phospho-STAT3, or phospho-Erk1/2 
mAbs for detection.
Immunoprecipitation
Cotransfected COS-7 cells were lysed in 20 mM Tris-HCl, pH 7.5, 
1 mM EDTA, 150 mM NaCl, 1 mM sodium vanadate, 10 mM sodium 
fluoride, 1 mM phenylmethylsulfonyl fluoride, and 1% Brij 97 supple-
mented with complete protease inhibitor cocktail tablets (Roche 
Diagnostics), and fibrosarcoma cells in 2fTGH and U1A in 20 mM 
Tris-HCl, pH 7.8, 130 mM NaCl, 0.5% NP-40, 0.5 mM EDTA, 1 mM 
sodium vanadate, and protease inhibitors (Haan and Haan, 2013). 
Cell debris was removed by centrifugation. Whole-cell extracts were 
incubated with α-Tyk2 (2 μg/ml rabbit polyclonal Ab or 1:50 C-20), 
α-Jak1 (1:50), or α-Jak2 (1:1000) mAb at 4°C overnight. We added 
50 μl of Protein A-Agarose (Roche Diagnostics) and incubated the 
samples at 4°C for 2 h under slow agitation. The samples were then 
washed three times with lysis buffer, suspended in 50 μl of 2.5× 
Laemmli sample buffer, and incubated for 10 min at 95°C. Analysis 
of interaction between cytokine receptor and respective Janus ki-
nase was done by Western blotting.
Western blotting
Defined amounts of proteins from cell lysates or coimmunopre-
cipitations were loaded per lane, separated by SDS-PAGE under 
reducing conditions, and transferred to polyvinylidene fluoride 
membranes. The membranes were blocked in 5% fat-free dried 
skimmed milk in TBS-T (10 mM Tris-HCl, pH 7.6, 150 mM NaCl, 
1% Tween-20) and probed with the indicated primary antibodies 
in 5% fat-free dried skimmed milk in TBS-T (α-STAT3, α-Jak2) or 
5% bovine serum albumin (BSA) in TBS-T (phospho-Jak2, phos-
pho-STAT3, phospho-STAT1, STAT1, phospho-Erk1/2, Erk1/2, 
mIL-23R, mIL-12Rβ1, V5, α-Tyk2, α-Jak1) at 4°C overnight. After 
washing, the membranes were incubated with streptavidin-HRP or 
secondary peroxidase-conjugated antibodies diluted in 5% BSA 
or 5% fat-free dried skimmed milk in TBS-T for 1 h at room tem-
perature. The ECL Prime Western Blotting Detection Reagent (GE 
Healthcare, Freiburg, Germany) and the ChemoCam Imager 
(INTAS Science Imaging Instruments, Göttingen, Germany) were 
used for signal detection. For reprobing with another primary 
antibody, the membranes were stripped in 62.5 mM Tris-HCl, 
pH 6.8, 2% SDS, and 0.1% β-mercaptoethanol for 30 min at 60°C 
and blocked again.
Cell surface detection of cytokine receptors
To detect cell surface expression of the cytokine receptors mIL-12Rβ2 
and mIL-23R, stably transduced Ba/F3-gp130 cells were washed 
with FACS buffer (PBS containing 1% BSA) and incubated at 
PCR using Phusion high-fidelity DNA polymerase (Thermo Fisher 
Scientific), followed by DpnI digestion of methylated template 
DNA. Box1 and Box2 deletion variants were generated by splicing 
with overlap extension PCR (SOE-PCR). Eukaryotic p409 expression 
plasmids for murine IL-23R (WT) and deletion (-Δ415, -Y416FΔ446, 
-Δ503, -Y416FΔ503) and mutation variants (-Y416F, -FFFF) were de-
scribed in Floss et al. (2013). The p409 expression vector containing 
the cDNA for the murine IL-23R was used as template for the gen-
eration of receptor variants with deletions of and within the mem-
brane-proximal region by standard and SOE-PCR. Mutation of argi-
nine 400 to glutamine was generated by PCR using Phusion 
high-fidelity DNA polymerase, followed by DpnI digestion of meth-
ylated template DNA. Resulting p409 expression vectors were veri-
fied by sequencing and used for transient transfection of U4C or 
COS-7 cells. The cDNA variants of mIL-12Rβ1 and mIL-23R variants 
were transferred into pMOWS-hygro or pMOWS-puro for retroviral 
transduction of Ba/F3-gp130 cells. The expression plasmid pEFm-
Tyk2 was described in Prchal-Murphy et al. (2012). The pEF/V5-His-
mJak2 plasmid was kindly provided by Eric Keil, David Finkenstädt, 
and Klaus Pfeffer (Institute of Medical Microbiology, Heinrich-Heine-
University, Düsseldorf, Germany). The pSVL-mJak1 was a generous 
gift from Iris Behrmann (Life Sciences Research Unit, University of 
Luxembourg, Luxembourg).
Transfection, transduction, and selection of cells
COS-7 and human fibrosarcoma cells (2C4, γ2A, U4C, 2fTGH, U1A) 
were transiently transfected with TurboFect (Thermo Fisher Scien-
tific) according to the manufacturer’s instructions. Ba/F3-gp130 cells 
were retrovirally transduced with the pMOWS expression plasmids 
coding for the various IL-23R and IL-12Rβ1 variants as described in 
Floss et al. (2013). In addition, Ba/F3-gp130-mIL-12Rβ2 cells were 
generated using the pMOWS-puro-IL-12Rβ2 vector. Transduced 
cells were grown in standard DMEM medium as described, supple-
mented with 10 ng/ml HIL-6. Selection of transduced Ba/F3 cells 
was performed with puromycin (1.5 μg/ml), hygromycin B (1 mg/ml; 
Carl Roth GmbH), or both for at least 2 wk. Then HIL-6 was washed 
away, and the generated Ba/F3-gp130 cell lines were selected for 
HIL-23– or HIL-12–dependent growth.
Cell viability assay
To remove the cytokines, Ba/F3-gp130 cell lines were washed three 
times with sterile phosphate-buffered saline (PBS). We suspended 5 
× 103 cells in DMEM supplemented with 10% fetal calf serum, 60 
mg/l penicillin, and 100 mg/l streptomycin and cultured them for 3 d 
in a final volume of 100 μl with or without cytokines as indicated. The 
CellTiter-Blue Cell Viability Assay (Promega, Karlsruhe, Germany) was 
used to estimate the number of viable cells by recording the fluores-
cence (excitation, 560 nm; emission, 590 nm) using the Infinite M200 
PRO plate reader (Tecan, Crailsheim, Germany) immediately after 
adding 20 μl of reagent per well (time point 0) and up to 1 h after 
incubation under standard cell culture conditions. All of the values 
were measured in triplicate per experiment. Fluorescence values 
were normalized by subtraction of values at time point 0. For direct 
comparison of the individual cell lines, proliferation in the presence of 
HIL-6 was defined as 100%. All experiments were performed at least 
three times, and one representative experiment was selected.
Stimulation assays
For analysis of STAT3 activation in cotransfected fibrosarcoma cell 
lines, cells were starved for 16 h in serum-free medium. This was 
followed by stimulation with cytokines as indicated. Subsequently 
cells were harvested and lysed in 50 mM Tris-HCl, pH 7.5, 150 mM 
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5 × 105 cells/100 μl FACS buffer supplemented with 2.5 μg of 
mIL-23R mAbs (R&D Systems) or 1 μg of purified hamster mIL-12Rβ2 
mAbs (BD Biosciences) for 2 h on ice. After a single wash with FACS 
buffer, cells were incubated in 100 μl of FACS buffer containing a 
1:100 dilution of Alexa Fluor 647–conjugated Fab goat anti-rat IgG 
(Dianova) or 0.25 μg PE mouse Armenian and Syrian hamster IgG 
cocktail (BD Biosciences) for 1 h at 4°C. Finally, cells were washed 
once with FACS buffer, suspended in 500 μl FACS buffer, and ana-
lyzed by flow cytometry (BD FACSCanto II flow cytometer; BD 
Biosciences). Data were evaluated using the FCS Express software 
(De Novo Software, Los Angeles, CA). Detection of surface expres-
sion of mIL-12Rβ1 was achieved by incubating cells prepared as 
described with 100 μl of FACS buffer containing 10 μl of PE-conju-
gated IL-12Rβ1 mAbs (R&D Systems) for 2 h at 4°C.
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